Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc

Amneal Pharmaceuticals Inc Price Chart AMRX

Historical daily share price chart and data for Amneal Pharmaceuticals Inc since 2009 adjusted for splits and dividends. The latest closing price for Amneal Pharmaceuticals Inc as of July 02, 2020 is $4.52.
  • In 2020 the stock opened at $4.98 and closed at $4.52 for a loss of -10% YTD.
  • In 2019 the stock opened at $13.33 and closed at $4.82 for a loss of -177%.
  • In 2018 the stock opened at $16.70 and closed at $13.53 for a loss of -23%.
  • In 2017 the stock opened at $13.50 and closed at $16.65 for a gain of 19%.
View Chart On Koyfin

Amneal Pharmaceuticals Inc Summary

Stock Symbol: AMRX

Amneal Pharmaceuticals Inc Company Info

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates in two segments, Generics and Specialty. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, manufacture, and sale of branded pharmaceutical products primarily for central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers licensed and owned, niche, and mature branded products, as well as Rytary for the treatment of Parkinsons Disease; Zomig for the treatment of migraine headaches; Emverm a chewable tablets for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; and Unithroid for the treatment of hypothyroidism. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It has operations in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is based in Bridgewater, New Jersey.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
582.84 %
30D Volatility
Hedge Fund Held
0 %

Last 10 Days of AMRX Prices